AR110106A1 - IMMUNOGLOBULINS AND USES OF THESE - Google Patents

IMMUNOGLOBULINS AND USES OF THESE

Info

Publication number
AR110106A1
AR110106A1 ARP170102981A ARP170102981A AR110106A1 AR 110106 A1 AR110106 A1 AR 110106A1 AR P170102981 A ARP170102981 A AR P170102981A AR P170102981 A ARP170102981 A AR P170102981A AR 110106 A1 AR110106 A1 AR 110106A1
Authority
AR
Argentina
Prior art keywords
immunoglobulins
therapeutic
couple
refers
life
Prior art date
Application number
ARP170102981A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR110106A1 publication Critical patent/AR110106A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente divulgación se refiere a una plataforma de anticuerpo monoclonal diseñada para acoplarse a péptidos terapéuticos para aumentar el periodo de semidesintegración del péptido terapéutico en un sujeto. Se refiere, además, a composiciones farmacéuticas y a métodos para su uso.The present disclosure relates to a monoclonal antibody platform designed to couple to therapeutic peptides to increase the half-life of the therapeutic peptide in a subject. It also refers to pharmaceutical compositions and methods for their use.

ARP170102981A 2016-10-27 2017-10-26 IMMUNOGLOBULINS AND USES OF THESE AR110106A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662413586P 2016-10-27 2016-10-27

Publications (1)

Publication Number Publication Date
AR110106A1 true AR110106A1 (en) 2019-02-27

Family

ID=65351710

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP170102981A AR110106A1 (en) 2016-10-27 2017-10-26 IMMUNOGLOBULINS AND USES OF THESE
ARP170102979A AR109895A1 (en) 2016-10-27 2017-10-26 CYCLICAL COMPOUNDS OF TYPOSINE TYPEOSEPHYPE PEPTIDE AS NEUROPEPTIDE MODULATORS AND RECEPTORS
ARP170102980A AR109979A1 (en) 2016-10-27 2017-10-26 CYCLICAL COMPOUNDS PEPTIDE TYPEOSINE-TYROSINE COUPLED TO ANTIBODIES AS MODULATORS OF NEUROPEPTIDE RECEPTORS AND

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP170102979A AR109895A1 (en) 2016-10-27 2017-10-26 CYCLICAL COMPOUNDS OF TYPOSINE TYPEOSEPHYPE PEPTIDE AS NEUROPEPTIDE MODULATORS AND RECEPTORS
ARP170102980A AR109979A1 (en) 2016-10-27 2017-10-26 CYCLICAL COMPOUNDS PEPTIDE TYPEOSINE-TYROSINE COUPLED TO ANTIBODIES AS MODULATORS OF NEUROPEPTIDE RECEPTORS AND

Country Status (1)

Country Link
AR (3) AR110106A1 (en)

Also Published As

Publication number Publication date
AR109979A1 (en) 2019-02-13
AR109895A1 (en) 2019-01-30

Similar Documents

Publication Publication Date Title
UY37456A (en) IMMUNOGLOBULINAS AND ITS USES
CO2018010458A2 (en) Anti-tim-3 antibodies and compositions
ECSP18082207A (en) NEOANTIGES AND METHODS OF USE
DOP2017000031A (en) ANTI-CTLA4 MONOCLONAL ANTIBODY OR ITS ANTIGEN BINDING FRAGMENT, A PHARMACEUTICAL COMPOSITION AND USE
CL2017001610A1 (en) Human antibodies to influenza hemagglutinin
CL2017003261A1 (en) Factor xi antibodies and methods of use
CO2018003477A2 (en) Anti-PD1 antibodies and methods of use
ECSP18096095A (en) ALPHA-SINUCLEIN ANTIBODIES AND USES OF THEM
EA201791093A1 (en) ANTIBODIES TO CD47, METHODS AND USE
BR112017006178A2 (en) fc region, antibodies, pharmaceutical formulation and uses of antibodies
EA201790569A1 (en) ANTIBODIES AND IMMUNOCONJUGATES AGAINST CLL-1
UY36021A (en) FC MULTIMÈRIC PROTEINS
MY185802A (en) Antibody formulation
EA201790239A1 (en) MOLECULE CARRIER FOR ANTIGENS
PE20161245A1 (en) SPECIFIC ANTIBODIES OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR AND USES OF THEM
BR112019001233A2 (en) pharmaceutical formulation and use thereof
CL2016001753A1 (en) Humanized monoclonal antibody that specifically binds to netrin-1, pharmaceutical compositions and uses of the antibody for cancer treatment
CU20170012A7 (en) ANTIBODIES ANTI PROTEIN SIMILAR TO ANGIOPOYETINA 4
EA201791049A1 (en) COMBINATION ANTI-CS1 AND ANTI-PD1 ANTIBODIES FOR CANCER TREATMENT (MYELOMA)
AR101671A1 (en) ANTIBODIES ANTI PROTEIN SIMILAR TO ANGIOPOYETINA-4 (ANGPTL4) AND METHODS OF USE
PE20180691A1 (en) VARIANTS OF IL-37
EA201990768A1 (en) OPTIMIZED SYNTHETIC CONSENSUS IMMUNOGENIC COMPOSITIONS AIMED AT FIBROBLAST ACTIVATION PROTEIN
MX2018014716A (en) Anti-tnfrsf25 antibodies.
AR110106A1 (en) IMMUNOGLOBULINS AND USES OF THESE
EA201991022A1 (en) IMMUNOGLOBULINS AND THEIR APPLICATION